Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Treasury Shares (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 12 years of Treasury Shares data on record, last reported at $387.7 million in Q3 2025.

  • For Q3 2025, Treasury Shares rose 33.33% year-over-year to $387.7 million; the TTM value through Sep 2025 reached $387.7 million, up 33.33%, while the annual FY2024 figure was $332.7 million, 34.47% up from the prior year.
  • Treasury Shares reached $172920.0 in Q3 2025 per AMPH's latest filing, down from $1.5 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.9 million in Q4 2024 and bottomed at -$13.6 million in Q1 2025.
  • Average Treasury Shares over 5 years is -$2.4 million, with a median of $204698.0 recorded in 2021.
  • Peak YoY movement for Treasury Shares: increased 15.72% in 2021, then skyrocketed 49.67% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $150.5 million in 2021, then increased by 25.95% to $189.5 million in 2022, then skyrocketed by 30.55% to $247.4 million in 2023, then skyrocketed by 34.47% to $332.7 million in 2024, then grew by 16.51% to $387.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $387.7 million in Q3 2025, $382.8 million in Q2 2025, and $343.9 million in Q1 2025.